Friday, July 19, 2024

3 Years On, Why Don’t We Know the Extent of Lengthy COVID?



Amesh Adalja, MD, senior scholar, Johns Hopkins College Middle for Well being Safety.

Manali Mukherjee, PhD, immunologist, assistant professor, Division of Respirology, Division of Drugs, McMaster College.

Sarah Wulf Hanson, PhD, analysis scientist, Institute for Well being Metrics and Analysis, College of Washington.

Lisa McCorkell, co-founder, Affected person-Led Analysis Collaborative.

Julia Moore Vogel, PhD, program director, Participant Middle, All of Us Analysis Program, Scripps Analysis Translational Institute.

The BMJ: “Lengthy COVID outcomes at one yr after gentle SARS-CoV-2 an infection: nationwide cohort examine.” 

Nature Evaluations Microbiology: “Lengthy COVID: Main findings, mechanisms and proposals.” 

CDC Nationwide Middle for Well being Statistics: “Lengthy COVID Family Pulse Survey.”

Nature Drugs: “Unexplained post-acute an infection syndromes.”

Affected person-Led Analysis Collaborative.

World Well being Group: “Put up COVID-19 situation (Lengthy COVID).”

CDC: “Put up-COVID Circumstances: CDC Science.”

The European Respiratory Journal: “Circulating anti-nuclear autoantibodies in COVID-19 survivors predict lengthy COVID signs.”

Rising Infectious Ailments: “Postacute Sequelae of SARS-CoV-2 in College Setting.”

Worldwide Extreme Acute Respiratory and rising An infection Consortium (ISARIC): “Medical Characterisation Protocol (CCP).”



Related Articles


Please enter your comment!
Please enter your name here

Latest Articles